These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8244820)

  • 21. What is your diagnosis? Mast cell tumour.
    Hess M
    J Small Anim Pract; 2006 Sep; 47(9):555-6. PubMed ID: 16961476
    [No Abstract]   [Full Text] [Related]  

  • 22. An immunohistochemical study of the expression of the hypoxia markers Glut-1 and Ca-IX in canine sarcomas.
    Abbondati E; Del-Pozo J; Hoather TM; Constantino-Casas F; Dobson JM
    Vet Pathol; 2013 Nov; 50(6):1063-9. PubMed ID: 23628694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterizing Microscopical Invasion Patterns in Canine Mast Cell Tumours and Soft Tissue Sarcomas.
    Russell DS; Townsend KL; Gorman E; Bracha S; Curran K; Milovancev M
    J Comp Pathol; 2017 Nov; 157(4):231-240. PubMed ID: 29169616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical detection of proliferative cells.
    Mokrý J; Nĕmecek S
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An enzyme-linked immunosorbent assay for hypoxia marker binding in tumours.
    Raleigh JA; La Dine JK; Cline JM; Thrall DE
    Br J Cancer; 1994 Jan; 69(1):66-71. PubMed ID: 8286212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in tumor hypoxia measured with a double hypoxic marker technique.
    Ljungkvist AS; Bussink J; Rijken PF; Raleigh JA; Denekamp J; Van Der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1529-38. PubMed ID: 11121659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical staining and radionuclide imaging of canine tumors, using a monoclonal antibody recognizing a synthetic carbohydrate antigen.
    Haines DM; Matte G; Wilkinson AA; Noujaim AA; Turner C; Longenecker BM
    Am J Vet Res; 1989 Jun; 50(6):875-81. PubMed ID: 2548421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an ELISA for the detection of 2-nitroimidazole hypoxia markers bound to tumor tissue.
    Raleigh JA; Zeman EM; Rathman M; LaDine JK; Cline JM; Thrall DE
    Int J Radiat Oncol Biol Phys; 1992; 22(3):403-5. PubMed ID: 1310494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound guided, pre-radiation oxygen measurements using polarographic oxygen needle electrodes in spontaneous canine soft tissue sarcomas.
    Achermann R; Ohlerth S; Fidel J; Gardelle O; Gassmann M; Roos M; Saunders HM; Scheid A; Wergin M; Kaser-Hotz B
    In Vivo; 2002; 16(6):431-7. PubMed ID: 12494886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marginal excision of low-grade spindle cell sarcoma of canine extremities: 35 dogs (1996-2006).
    Stefanello D; Morello E; Roccabianca P; Iussich S; Nassuato C; Martano M; Squassino C; Avallone G; Romussi S; Buracco P
    Vet Surg; 2008 Jul; 37(5):461-5. PubMed ID: 18986313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of the hypoxia-activated pro-drug TH-302 in hypoxic and perivascular regions of solid tumors and its potential to enhance therapeutic effects of chemotherapy.
    Saggar JK; Tannock IF
    Int J Cancer; 2014 Jun; 134(11):2726-34. PubMed ID: 24338277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unclassified sarcomas: a study to improve classification in a cohort of Golden Retriever dogs.
    Boerkamp KM; Hellmén E; Willén H; Grinwis GC; Teske E; Rutteman GR
    J Vet Diagn Invest; 2016 Nov; 28(6):623-631. PubMed ID: 27698172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of nuclear morphometry in the cytologic evaluation of canine cutaneous soft tissue sarcomas.
    Meachem MD; Burgess HJ; Davies JL; Kidney BA
    J Vet Diagn Invest; 2012 May; 24(3):525-30. PubMed ID: 22529119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demonstration of tryptase in bovine cutaneous and tumor mast cells.
    Welle MM; Proske SM; Harvima IT; Schechter NM
    J Histochem Cytochem; 1995 Nov; 43(11):1139-44. PubMed ID: 7560896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumor model.
    Ljungkvist AS; Bussink J; Kaanders JH; Wiedenmann NE; Vlasman R; van der Kogel AJ
    Radiat Res; 2006 Mar; 165(3):326-36. PubMed ID: 16494521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is Ki-67 a better proliferative marker in the colon than proliferating cell nuclear antigen?
    Holt PR; Moss SF; Kapetanakis AM; Petrotos A; Wang S
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):131-5. PubMed ID: 9037564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histologic grade predicts recurrence for marginally excised canine subcutaneous soft tissue sarcomas.
    McSporran KD
    Vet Pathol; 2009 Sep; 46(5):928-33. PubMed ID: 19429989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.